Fasting Plasma Glucose and Glycated Hemoglobin Levels as Risk Factors for the Development of Hypertension: A Retrospective Cohort Study
Beibei Luo,Lei Feng,Qianye Bi,Rui Shi,Huiying Cao,Yanbi Zhang
DOI: https://doi.org/10.2147/DMSO.S410670
2023-06-17
Abstract:Beibei Luo, 1 Lei Feng, 2 Qianye Bi, 1 Rui Shi, 1 Huiying Cao, 1 Yanbi Zhang 1 1 Department of Laboratory, The Sixth Affiliated Hospital of Kunming Medical University, Yuxi City, Yunnan Province, 653100, People's Republic of China; 2 Intensive Care Unit, People's Hospital of Yuxi City, Yuxi City, Yunnan Province, 653100, People's Republic of China Correspondence: Lei Feng, Department of Laboratory, The Sixth Affiliated Hospital of Kunming Medical University, 21 Nieer Road, Yuxi City, Yunnan Province, 653100, People's Republic of China, Email Introduction: Hypertension (HTN) is a significant risk factor for cardiovascular disease. Identifying new risk factors for hypertension is crucial. This study aims to determine the predictive value of fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c) in the development of hypertension. Methods: In this study, we examined 16,026 individuals without diabetes and other cardiovascular risk factors who were underwent annual screening at the People's Hospital of Yuxi, Yunnan, China from 2013 to 2016. The participants were divided into two groups: normoglycemic and prediabetic. Normoglycemia was defined as having an HbA1c level of less than 5.7% and an FPG level of less than 5.6 mmol/ L. Prediabetes was defined according to the ADA criteria, which includes having an HbA1c level between 5.7% and 6.5%, or an impaired fasting glucose level between 5.6 mmol/L and 7.0 mmol/L. The participants were further divided into four subgroups based on their FPG and HbA1c levels: normoglycemia, impaired HbA1c only, FPG only, and both parameters impaired. Results: The cohort study was conducted on 16,026 participants from Yunnan, China, consisting of 60.6% males and 39.4% females, with a mean age of 44.6 ± 12.5 years. The study revealed that prediabetes was independently associated with an increased risk for HTN (OR 1.53, 95% CI 1.41~1.67, P < 0.001). The analysis of different subgroups of HbA1c and FPG showed that FPG was a better predictor of HTN than HbA1c, regardless of the group. Conclusion: FPG and HbA1c were significantly associated with the future development of HTN in individuals with prediabetes. Keywords: glycated hemoglobin, glucose, hypertension Hypertension (HTN) is a significant risk factor for cardiovascular disease, 1 and it remains a major health concern globally. Approximately 40% of adults worldwide are affected by HTN, which leads to over 9.4 million deaths annually. 2 Therefore, identifying new risk factors for HTN is crucial in promoting preventive treatment for cardiovascular diseases. Research has shown that up to one-third of hypertensive individuals have insulin resistance, which meets the diagnostic criteria for metabolic syndrome. 3 Insulin resistance is a key indicator of prediabetes and diabetes, 4 conditions that are strongly associated with the development of HTN. 5 Previous research has demonstrated a correlation between glycated hemoglobin (HbA1c) and fasting plasma glucose (FPG) tests and hypertension and cardiovascular disease. 6–8 Furthermore, FPG and HbA1c tests are straightforward methods for determining insulin resistance. 9 The American Diabetes Association (ADA) 2003 diagnostic criteria, 10 which defined impaired fasting glucose (IFG) as blood glucose between 6.1 and 7.0 mmol/ L, and impaired glucose tolerance (IGT) as a 2-hour postprandial blood glucose of between 7.8 and 11.1 mmol/ L, are predictors for the future development of diabetes and diabetes-related complications, including HTN. However, due to confounding factors, it remains unclear whether FPG and HbA1c tests serve as independent risk factors for hypertension development. Although increased concentrations of FPG or HbA1c have been reported to have predictive power for the development of hypertension, it is unclear whether there is an association between elevated FPG levels or HbA1c in non-diabetic patients at the increased risk of hypertension. In this study, we aimed to determine the predictive value of FPG and HbA1c for the development of hypertension in a group of participants who had not been previously diagnosed with hypertension and diabetes at baseline. This single-center, retrospective cohort study was conducted at People's Hospital of Yuxi, Yunnan, China and included a cohort of 31,180 apparently healthy employees who underwent annual medical examinations between 2013 and 2016. All participants underwent anthropometric measurements and biochemical tests, while trained professionals performed standardized measurements according to a working protocol. Participants' height and weight were measured and recorded while wearing l -Abstract Truncated-
endocrinology & metabolism